MarketPeel
Insider Trading Intelligence
Pricing
…
Christopher Hite
Thu, Apr 16, 2026
Apr 16
received an award in
KLRA
38,300
shares @ $0.00
New position
KLRA
Kailera Therapeutics, Inc.
Manufacturing
Pharmaceutical Preparations
1D
0.00%
1W
-4.29%
1M
-2.94%
3M
—
6M
—
1Y
—
Recent insider activity at KLRA
Apr 20
Rtw Investments, Lp
Bought
$8.00m
Apr 20
Bain Capital Life Sciences Fund Iv, L.p.
Bought
$25.00m
Apr 20
Andrew T. Kaplan
Bought
$134.38m
Full KLRA profile →
Christopher Hite’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback